Clinical Trials Browser

Uterine Cervical Neoplasms, Vaginal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaccinia

Locally Advanced Cervical Adenocarcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Advanced Cervical Cancer

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Locally Advanced Cervical Carcinoma

Uterine Cervical Neoplasms

Locally Advanced Cervical Cancer

Endometrial Clear Cell Adenocarcinoma

Uterine Cervical Neoplasms

Endometrial Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Gestational Trophoblastic Disease

Uterine Cervical Neoplasms

Ovarian Neoplasms

Recurrent Uterine Corpus Carcinoma

Endometrial Clear Cell Adenocarcinoma

Ovarian Germ Cell Cancer, Teratoma, Testicular Neoplasms, Endodermal Sinus Tumor

Endometrial Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Hyperthermia, Uterine Cervical Neoplasms

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Uterine Cervical Neoplasms, Lymphocele

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Recurrence

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Clinical Trials

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

TroFuse-036

KEYNOTE-A18

KEYNOTE-826

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

HOTT

A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

KEYNOTE-B21

MICHELE

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

INTERLACE

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

AK104-305

AddChemo

CALLA

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

PORTEC-3

ONCOCOL01

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

MOGCT-01

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

FERMATA

Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

TACO

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

SYSGO-003

mEHT

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer

CERVIPIB

Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients

Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients

Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer